Page last updated: 2024-09-04

docetaxel anhydrous and Carcinoma, Bronchogenic

docetaxel anhydrous has been researched along with Carcinoma, Bronchogenic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Manegold, C	1

Reviews

1 review(s) available for docetaxel anhydrous and Carcinoma, Bronchogenic

Article	Year
[Docetaxel (taxotere): current status of clinical development in non-small-cell bronchial carcinoma (NSCLC)]. Medizinische Klinik (Munich, Germany : 1983), 1998, Sep-15, Volume: 93 Suppl 3 Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Lung Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome	1998

Article

Year

[Docetaxel (taxotere): current status of clinical development in non-small-cell bronchial carcinoma (NSCLC)].

Medizinische Klinik (Munich, Germany : 1983), 1998, Sep-15, Volume: 93 Suppl 3

Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Docetaxel; Humans; Lung Neoplasms; Paclitaxel; Randomized Controlled Trials as Topic; Taxoids; Treatment Outcome

1998